78
TELA Bio receives FDA 510(k) clearance for Liora Monofilament Scaffold
Why it matters
TELA Bio announced FDA 510(k) clearance for its Liora Monofilament Scaffold product, a regulatory milestone that enables commercial distribution of the medical device. 510(k) clearance is a significant approval gate for medical device manufacturers and typically expands revenue opportunities in the cleared indication.
In plain language
TELA Bio got official government approval to sell a new wound-healing device called Liora Monofilament Scaffold, which allows the company to start generating revenue from this product.
Exposure
TELA ▲
Price check
not measured: no fresh price at the time of scoringHow this is measured
Information only. AURA does not give buy or sell recommendations.